226 related articles for article (PubMed ID: 23017622)
1. Evaluation of treatment- and disease-related symptoms in advanced head and neck cancer: validation of the national comprehensive cancer network-functional assessment of cancer therapy-head and neck cancer symptom index-22 (NFHNSI-22).
Pearman TP; Beaumont JL; Paul D; Abernethy AP; Jacobsen PB; Syrjala KL; Von Roenn J; Cella D
J Pain Symptom Manage; 2013 Jul; 46(1):113-20. PubMed ID: 23017622
[TBL] [Abstract][Full Text] [Related]
2. Priority symptoms in advanced breast cancer: development and initial validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16).
Garcia SF; Rosenbloom SK; Beaumont JL; Merkel D; Von Roenn JH; Rao D; Cella D
Value Health; 2012 Jan; 15(1):183-90. PubMed ID: 22264987
[TBL] [Abstract][Full Text] [Related]
3. Validation of brief symptom indexes among patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A trial of the ECOG-ACRIN Cancer Research Group (E1302).
Oswald LB; Lee JW; Argiris A; Webster KA; Forastiere AA; Cella D
Cancer Med; 2020 Dec; 9(23):8884-8894. PubMed ID: 33040481
[TBL] [Abstract][Full Text] [Related]
4. Development of a symptom index for patients with primary brain tumors.
Lai JS; Jensen SE; Beaumont JL; Abernethy AP; Jacobsen PB; Syrjala K; Raizer JJ; Cella D
Value Health; 2014; 17(1):62-9. PubMed ID: 24438718
[TBL] [Abstract][Full Text] [Related]
5. A brief symptom index for advanced lung cancer.
Yount S; Beaumont J; Rosenbloom S; Cella D; Patel J; Hensing T; Jacobsen PB; Syrjala K; Abernethy AP
Clin Lung Cancer; 2012 Jan; 13(1):14-23. PubMed ID: 21729652
[TBL] [Abstract][Full Text] [Related]
6. Psychometric Validation of the M. D. Anderson Symptom Inventory-Head and Neck Module in the Spanish Language.
Sánchez D; Chala A; Alvarez A; Payan C; Mendoza T; Cleeland C; Sanabria A
J Pain Symptom Manage; 2016 Jun; 51(6):1055-61. PubMed ID: 26899822
[TBL] [Abstract][Full Text] [Related]
7. A preliminary study of a health related quality of life assessment of priority symptoms in advanced lymphoma: the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy - Lymphoma Symptom Index.
Hlubocky FJ; Webster K; Beaumont J; Cashy J; Paul D; Abernethy A; Syrjala KL; Von Roenn J; Cella D
Leuk Lymphoma; 2013 Sep; 54(9):1942-6. PubMed ID: 23320888
[TBL] [Abstract][Full Text] [Related]
8. Validation of the MD Anderson Symptom Inventory-Head-and-Neck-Filipino (MDASI-HN-F): clinical utility of symptom screening among patients with head-and-neck cancer.
Bacorro WR; Sy Ortin TT; Suarez CG; Mendoza TR; Que JC
BMJ Support Palliat Care; 2017 Jun; 7(2):140-149. PubMed ID: 25941198
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a symptom index for advanced hepatobiliary and pancreatic cancers: the National Comprehensive Cancer Network Functional Assessment of Cancer Therapy (NCCN-FACT) Hepatobiliary-Pancreatic Symptom Index (NFHSI).
Butt Z; Parikh ND; Beaumont JL; Rosenbloom SK; Syrjala KL; Abernethy AP; Benson AB; Cella D
Cancer; 2012 Dec; 118(23):5997-6004. PubMed ID: 22605658
[TBL] [Abstract][Full Text] [Related]
10. Optimizing brief, focused assessment of priority symptoms and concerns in recurrent and/or metastatic squamous cell carcinoma of the head and neck: Content validation of the Functional Assessment of Cancer Therapy/National Comprehensive Cancer Network Head and Neck Symptom Index-10 (FHNSI-10).
Shaunfield S; Yount SE; Boyken L; Agulnik M; Samant S; Cella D
Health Sci Rep; 2021 Dec; 4(4):e401. PubMed ID: 34708159
[TBL] [Abstract][Full Text] [Related]
11. Development and initial validation of the NCCN/FACT symptom index for advanced kidney cancer.
Rothrock NE; Jensen SE; Beaumont JL; Abernethy AP; Jacobsen PB; Syrjala K; Cella D
Value Health; 2013; 16(5):789-96. PubMed ID: 23947972
[TBL] [Abstract][Full Text] [Related]
12. PROMIS evaluation for head and neck cancer patients: a comprehensive quality-of-life outcomes assessment tool.
Stachler RJ; Schultz LR; Nerenz D; Yaremchuk KL
Laryngoscope; 2014 Jun; 124(6):1368-76. PubMed ID: 24719292
[TBL] [Abstract][Full Text] [Related]
13. Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module.
Rosenthal DI; Mendoza TR; Chambers MS; Asper JA; Gning I; Kies MS; Weber RS; Lewin JS; Garden AS; Ang KK; S Wang X; Cleeland CS
Head Neck; 2007 Oct; 29(10):923-31. PubMed ID: 17358040
[TBL] [Abstract][Full Text] [Related]
14. Development of a Patient-Centered Functional Outcomes Questionnaire in Head and Neck Cancer.
Mendez A; Seikaly H; Eurich D; Dzioba A; Aalto D; Osswald M; Harris JR; O'Connell DA; Lazarus C; Urken M; Likhterov I; Chai RL; Rauscher E; Buchbinder D; Okay D; Happonen RP; Kinnunen I; Irjala H; Soukka T; Laine J;
JAMA Otolaryngol Head Neck Surg; 2020 May; 146(5):437-443. PubMed ID: 32271362
[TBL] [Abstract][Full Text] [Related]
15. Italian version of the M.D. Anderson Symptom Inventory--Head and Neck Module: linguistic validation.
Greco A; Orlandi E; Mirabile A; Takanen S; Fallai C; Iacovelli NA; Rimedio A; Russi E; Sala M; Monzani D; Rosenthal DI; Gunn GB; Steca P; Licitra L; Bossi P
Support Care Cancer; 2015 Dec; 23(12):3465-72. PubMed ID: 25791393
[TBL] [Abstract][Full Text] [Related]
16. Comparing the patients' subjective experiences of acute side effects during radiotherapy for head and neck cancer with four different patient-reported outcomes questionnaires.
Holländer-Mieritz C; Johansen J; Johansen C; Vogelius IR; Kristensen CA; Pappot H
Acta Oncol; 2019 May; 58(5):603-609. PubMed ID: 30698098
[No Abstract] [Full Text] [Related]
17. Vanderbilt head and neck symptom survey, version 2.0: Clinical and research utility for identification of symptom clusters and changes in symptoms over time.
Ridner SH; Rhoten BA; Niermann KJ; Murphy BA; Dietrich MS
Oral Oncol; 2018 Aug; 83():25-31. PubMed ID: 30098775
[TBL] [Abstract][Full Text] [Related]
18. What are the most important symptom targets when treating advanced cancer? A survey of providers in the National Comprehensive Cancer Network (NCCN).
Cella D; Paul D; Yount S; Winn R; Chang CH; Banik D; Weeks J
Cancer Invest; 2003; 21(4):526-35. PubMed ID: 14533442
[TBL] [Abstract][Full Text] [Related]
19. Reliability and validity of the Vanderbilt Head and Neck Symptom Survey: a tool to assess symptom burden in patients treated with chemoradiation.
Murphy BA; Dietrich MS; Wells N; Dwyer K; Ridner SH; Silver HJ; Gilbert J; Chung CH; Cmelak A; Burkey B; Yarbrough WG; Sinard R; Netterville J
Head Neck; 2010 Jan; 32(1):26-37. PubMed ID: 19626644
[TBL] [Abstract][Full Text] [Related]
20. Development of a head and neck companion module for the quality of life-radiation therapy instrument (QOL-RTI).
Trotti A; Johnson DJ; Gwede C; Casey L; Sauder B; Cantor A; Pearlman J
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):257-61. PubMed ID: 9788402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
